Shandong
605016.SSShandong Bailong Chuangyuan Bio-Tech Co., Ltd. Price (605016.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
247,430,350
(0.3819)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 335,524,100 | 310,609,700 | 355,533,959 | 421,053,343 | 499,624,283 | 653,356,099 | 721,893,633 | 868,259,729 |
| Net Income | 64,798,500 | 63,733,900 | 65,304,383 | 82,783,167 | 95,552,192 | 104,479,175 | 150,751,364 | 192,995,673 |
| FCF USD | 32,024,100 | 76,810,600 | 1,009,867 | 7,592,803 | 63,162,838 | 40,378,807 | -25,783,024 | -117,344,924 |
| OCF USD | 60,100,400 | 113,469,200 | 89,119,808 | 64,079,025 | 121,820,415 | 96,195,458 | 149,815,201 | 194,632,929 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| D/E | 0.57 | 0.32 | 0.11 | 0.09 | 0.10 | 0.00 | 0.00 | 0.00 |
| CA/CL | 1.24 | 1.68 | 2.33 | 1.93 | 2.76 | 11.68 | 7.06 | 3.20 |
| TA/TL | 2.35 | 3.30 | 5.64 | 4.80 | 5.77 | 16.22 | 11.59 | 7.12 |
| Total Debt | 208,066,700 | 138,000,000 | 55,900,000 | 53,900,000 | 68,500,000 | 2,515,364 | 1,450,013 | 627,320 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 10.77% | 11.14% | 11.81% | 12.83% | 12.50% | 8.73% | 11.38% | 12.89% |
| ROE | 17.87% | 14.60% | 13.02% | 13.86% | 13.83% | 8.68% | 11.21% | 12.80% |
| ROA | 0.00% | 10.18% | 10.71% | 10.97% | 11.43% | 8.15% | 10.24% | 11.00% |
| NM % | 19.31% | 20.52% | 18.37% | 19.66% | 19.12% | 15.99% | 20.88% | 22.23% |
| FCF / R% | 0.00% | 24.73% | 0.28% | 1.80% | 12.64% | 6.18% | -3.57% | -13.51% |
| FCF / NI% | 49.42% | 120.52% | 1.55% | 9.17% | 66.10% | 38.65% | -17.10% | -60.80% |
| Operating Margin (OM) | 0.00 | 0.24 | 0.38 | 0.49 | 0.59 | 0.59 | 0.71 | 0.76 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.41 | 0.34 | 0.69 | 0.33 | 0.38 | 0.42 | 0.61 | 0.78 |
| SPS | 2.11 | 1.67 | 3.76 | 1.69 | 2.01 | 2.63 | 2.91 | 3.51 |
| OCPS | 0.38 | 0.61 | 0.94 | 0.26 | 0.49 | 0.39 | 0.60 | 0.79 |
| FCPS | 0.20 | 0.41 | 0.01 | 0.03 | 0.25 | 0.16 | -0.10 | -0.47 |
| BVPS | 2.28 | 2.34 | 5.30 | 2.40 | 2.78 | 4.84 | 5.41 | 6.09 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.41 | 0.34 | 0.69 | 0.33 | 0.38 | 0.42 | 0.61 | 0.78 |
| CAGR-SPS | 2.11 | 1.67 | 3.76 | 1.69 | 2.01 | 2.63 | 2.91 | 3.51 |
| CAGR-OCPS | 0.38 | 0.61 | 0.94 | 0.26 | 0.49 | 0.39 | 0.60 | 0.79 |
| CAGR-FCPS | 0.20 | 0.41 | 0.01 | 0.03 | 0.25 | 0.16 | -0.10 | -0.47 |
| CAGR-BVPS | 2.28 | 2.34 | 5.30 | 2.40 | 2.78 | 4.84 | 5.41 | 6.09 |